A Nanozyme‐Based Artificial Peroxisome Ameliorates Hyperuricemia and Ischemic Stroke

Author:

Xi Juqun1,Zhang Ruofei2,Wang Liming3,Xu Wei4,Liang Qian2,Li Jingyun5,Jiang Jian1,Yang Yili6,Yan Xiyun27,Fan Kelong27,Gao Lizeng27ORCID

Affiliation:

1. Department of Pharmacology School of Medicine Institute of Translational Medicine Yangzhou University Yangzhou 225001 P. R. China

2. CAS Engineering Laboratory for Nanozyme Key Laboratory of Protein and Peptide Pharmaceutical Institute of Biophysics University of Chinese Academy of Sciences Chinese Academy of Sciences Beijing 100101 P. R. China

3. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety Beijing Synchrotron Radiation Facility Institute of High Energy Physics Beijing 100049 P. R. China

4. Beijing Synchrotron Radiation Facility Institute of High Energy Physics Beijing 100049 P. R. China

5. Key Laboratory of Infection and Immunity Institute of Biophysics Chinese Academy of Sciences Beijing 100101 P. R. China

6. Suzhou Institute of Systems Medicine Center for Systems Medicine Chinese Academy of Medicine Sciences Suzhou 215123 P. R. China

7. Nanozyme Medical Center School of Basic Medical Sciences Zhengzhou University Zhengzhou 450052 P. R. China

Funder

National Natural Science Foundation of China

Chinese Academy of Sciences

National Basic Research Program of China

Youth Innovation Promotion Association of the Chinese Academy of Sciences

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Cited by 169 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3